FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144013753> ?p ?o ?g. }

• W2144013753 endingPage "888" @default.
• W2144013753 startingPage "879" @default.
• W2144013753 abstract "OBJECTIVE—The reactions of carbohydrate- or lipid-derived intermediates with proteins lead to the formation of Maillard reaction products, which subsequently leads to the formation of advanced glycation/lipoxidation end products (AGE/ALEs). Levels of AGE/ALEs are increased in diseases like diabetes. Unlike AGEs, very little is known about ALE effects in vitro. We hypothesized that ALEs can have proinflammatory effects in monocytes. RESEARCH DESIGN AND METHODS—In a profiling approach, conditioned media from THP-1 cells either cultured in normal glucose (5.5 mmol/l) or treated with MDA-Lys or MDA alone were hybridized to arrays containing antibodies to 120 known human cytokines/chemokines. Pathway analyses with bioinformatics software were used to identify signalling networks. RESULTS—Synthetic ALE (malondialdehyde-lysine [MDA-Lys]) (50 μmol/l) could induce oxidant stress and also activate the transcriptional factor nuclear factor-κB (NF-κB) in THP-1 monocytes. MDA-Lys also significantly increased the expression of key candidate proinflammatory genes, interferon-γ–inducible protein-10, β1- and β2-integrins, cyclooxygenase-2 (COX-2), monocyte chemoattractant protein-1 (MCP-1), interleukin-6 and -8, and inducible nitric-oxide synthase, which are also associated with monocyte dysfunction. Several key target proinflammatory proteins were significantly induced by MDA-Lys relative to normal glucose or MDA alone, including MCP-1; tumor necrosis factor ligand superfamily member-14; chemokine CC motif ligand-11 (CCL11); growth-related oncogene-α, -β, and -γ; and chemokine CXC motif ligand-13. Bioinformatics analyses identified a network of chemokine signaling among MDA-Lys–regulated genes. MDA-Lys also increased monocyte binding to vascular smooth muscle and endothelial cells. Furthermore, plasma from diabetic rats showed significantly higher levels of MDA-Lys and CCL11. CONCLUSIONS—These new results suggest that ALEs can promote monocyte activation and vascular complications via induction of inflammatory pathways and networks." @default.
• W2144013753 created "2016-06-24" @default.
• W2144013753 creator A5029689967 @default.
• W2144013753 creator A5044129120 @default.
• W2144013753 creator A5044566437 @default.
• W2144013753 creator A5077094708 @default.
• W2144013753 creator A5079634326 @default.
• W2144013753 creator A5086999864 @default.
• W2144013753 date "2008-04-01" @default.
• W2144013753 modified "2023-10-11" @default.
• W2144013753 title "Proinflammatory Effects of Advanced Lipoxidation End Products in Monocytes" @default.
• W2144013753 cites W1529592271 @default.
• W2144013753 cites W1594856996 @default.
• W2144013753 cites W1843398852 @default.
• W2144013753 cites W1968233853 @default.
• W2144013753 cites W1968963416 @default.
• W2144013753 cites W1970904679 @default.
• W2144013753 cites W1978574835 @default.
• W2144013753 cites W1978793468 @default.
• W2144013753 cites W1982172912 @default.
• W2144013753 cites W1998614770 @default.
• W2144013753 cites W2006441826 @default.
• W2144013753 cites W2007359045 @default.
• W2144013753 cites W2007684714 @default.
• W2144013753 cites W2011988431 @default.
• W2144013753 cites W2044437167 @default.
• W2144013753 cites W2047002611 @default.
• W2144013753 cites W2066520602 @default.
• W2144013753 cites W2066963386 @default.
• W2144013753 cites W2087695736 @default.
• W2144013753 cites W2094212401 @default.
• W2144013753 cites W2097703150 @default.
• W2144013753 cites W2098407973 @default.
• W2144013753 cites W2098587915 @default.
• W2144013753 cites W2098646953 @default.
• W2144013753 cites W2102647393 @default.
• W2144013753 cites W2111867309 @default.
• W2144013753 cites W2113311606 @default.
• W2144013753 cites W2119563494 @default.
• W2144013753 cites W2121168048 @default.
• W2144013753 cites W2132517655 @default.
• W2144013753 cites W2142920097 @default.
• W2144013753 cites W2143027219 @default.
• W2144013753 cites W2146742006 @default.
• W2144013753 cites W2161624379 @default.
• W2144013753 cites W2186760511 @default.
• W2144013753 cites W2921356930 @default.
• W2144013753 doi "https://doi.org/10.2337/db07-1204" @default.
• W2144013753 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2695452" @default.
• W2144013753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18003754" @default.
• W2144013753 hasPublicationYear "2008" @default.
• W2144013753 type Work @default.
• W2144013753 sameAs 2144013753 @default.
• W2144013753 citedByCount "77" @default.
• W2144013753 countsByYear W21440137532012 @default.
• W2144013753 countsByYear W21440137532013 @default.
• W2144013753 countsByYear W21440137532014 @default.
• W2144013753 countsByYear W21440137532015 @default.
• W2144013753 countsByYear W21440137532016 @default.
• W2144013753 countsByYear W21440137532017 @default.
• W2144013753 countsByYear W21440137532018 @default.
• W2144013753 countsByYear W21440137532019 @default.
• W2144013753 countsByYear W21440137532020 @default.
• W2144013753 countsByYear W21440137532021 @default.
• W2144013753 countsByYear W21440137532022 @default.
• W2144013753 countsByYear W21440137532023 @default.
• W2144013753 crossrefType "journal-article" @default.
• W2144013753 hasAuthorship W2144013753A5029689967 @default.
• W2144013753 hasAuthorship W2144013753A5044129120 @default.
• W2144013753 hasAuthorship W2144013753A5044566437 @default.
• W2144013753 hasAuthorship W2144013753A5077094708 @default.
• W2144013753 hasAuthorship W2144013753A5079634326 @default.
• W2144013753 hasAuthorship W2144013753A5086999864 @default.
• W2144013753 hasBestOaLocation W21440137531 @default.
• W2144013753 hasConcept C13373296 @default.
• W2144013753 hasConcept C164027704 @default.
• W2144013753 hasConcept C170493617 @default.
• W2144013753 hasConcept C17991360 @default.
• W2144013753 hasConcept C185592680 @default.
• W2144013753 hasConcept C203014093 @default.
• W2144013753 hasConcept C2776914184 @default.
• W2144013753 hasConcept C2781184567 @default.
• W2144013753 hasConcept C55493867 @default.
• W2144013753 hasConcept C86803240 @default.
• W2144013753 hasConceptScore W2144013753C13373296 @default.
• W2144013753 hasConceptScore W2144013753C164027704 @default.
• W2144013753 hasConceptScore W2144013753C170493617 @default.
• W2144013753 hasConceptScore W2144013753C17991360 @default.
• W2144013753 hasConceptScore W2144013753C185592680 @default.
• W2144013753 hasConceptScore W2144013753C203014093 @default.
• W2144013753 hasConceptScore W2144013753C2776914184 @default.
• W2144013753 hasConceptScore W2144013753C2781184567 @default.
• W2144013753 hasConceptScore W2144013753C55493867 @default.
• W2144013753 hasConceptScore W2144013753C86803240 @default.
• W2144013753 hasIssue "4" @default.
• W2144013753 hasLocation W21440137531 @default.
• W2144013753 hasLocation W21440137532 @default.
• W2144013753 hasLocation W21440137533 @default.

• next